logo image
search icon
Global CD Targeted Bispecific Antibody Market

CD Targeted Bispecific Antibody Market Size, Share & Trends Analysis Report By Target Type (CD3, CD19 and CD30/CD16A), Region And Segment Forecasts, 2023-2031.

Report ID : 1144 | Published : 2023-07-23 | Pages: 160 | Format: PDF/EXCEL

The CD Targeted Bispecific Antibody Market is expected at an XX % CAGR during the forecast period for 2023-2031.

CD Targeted Bispecific Antibody Market

InsightAce Analytic’s “Global CD Targeted Bispecific Antibody Market Research Report 2023” is a comprehensive analysis, forecast, market dynamics and major trends report covering key market data on the CD Targeted Bispecific Antibody target type segments. This market research report provides market estimation and forecast for value (US$), within CD Targeted Bispecific Antibody Market segments. The oncology market today could be quickly superseded by next-generation therapies in the upcoming forecast period. The CD Targeted Bispecific Antibody Market is driven by factors such as the rising prevalence of cancer, increasing research funding in the immune-oncology, and focus on research activities from government health institutions and pharma giants in Immuno-oncology therapy development.

The Global CD Targeted Bispecific Antibody Market is segmented on the basis of target type and region. Based on the target type, the CD Targeted Bispecific Antibody Market is divided into CD3, CD19 and CD30/CD16A. Based on region, the market is studied across North America, Asia-Pacific, Europe, Latin America, and Middle East & Africa. Among that, North America held the largest share of the market, followed by Europe. On the other hand, Asia-Pacific is expected to dominate the CD Targeted Bispecific Antibody Market during the analysis of the forecast period.

Key insights included in the report

  • This InsightAce Analytic report will help to develop sales strategies by understanding the trends shaping and driving
  • Organize marketing and sales efforts by identifying the best opportunities for CD Targeted Bispecific Antibody Market
  • This report offers analysis or key insights to understand the future market competition in the CD Targeted Bispecific Antibody Market.
  • Key features of CD Targeted Bispecific Antibody product which makes them a better choice over substitute product with inclusion of Porter’s Five Forces Analysis
  • How did the CD Targeted Bispecific Antibody Market evolve and what is its scope in the future
  • Key development strategies which are implemented by the key players to maintain and capture market share
  • Analysis of major market drivers, challenges, and opportunities in the global CD Targeted Bispecific Antibody Market
  • Insights on the current leading companies dominating the global CD Targeted Bispecific Antibody Market
  • The market analysis and forecast of the leading segments and sub-segments of the global CD Targeted Bispecific Antibody industry
  • Analysis of each segment of the global CD Targeted Bispecific Antibody Market expected to grow during the forecast period 2022-2031.

Competitive Landscape

Some of The Key Players in The CD Targeted Bispecific Antibody Market:

  • Aptevo Therapeutics
  • Affimed GmbH
  • Sutro Biopharma, Inc.
  • IGM Biosciences, Inc.
  • Xencor, Inc.
  • Amgen Inc.
  • Genentech USA, Inc.
  • Astella Pharma Inc.
  • Ben Kang Biopharmaceutical (Shenzhen) Co., Ltd.
  • Merus
  • Regeneron Pharmaceuticals, Inc.
  • Other Prominent Players

 

The CD Targeted Bispecific Antibody Market Report Scope

Report Attribute

Specifications

Growth Rate CAGR

CAGR of XX % from 2023 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2023 to 2031

Historic Year

2019 to 2022

Forecast Year

2023-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Target Type

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia

Competitive Landscape

Aptevo Therapeutics, Affimed GmbH, Sutro Biopharma, Inc., IGM Biosciences, Inc., Xencor, Inc., Amgen Inc., Genentech USA, Inc., Astella Pharma Inc., Ben Kang Biopharmaceutical (Shenzhen) Co., Ltd., Merus, and Regeneron Pharmaceuticals, Inc., and others

Customization Scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

 

 

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global CD Targeted Bispecific Antibody Market Snapshot

Chapter 4. Global CD Targeted Bispecific Antibody Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Target Type Estimates & Trend Analysis

5.1. By Target Type & Market Share, 2022 & 2030

5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 for the following By Target Type:

5.2.1. CD3

5.2.2. CD19

5.2.3. CD30/CD16A

Chapter 6. CD Targeted Bispecific Antibody Market Segmentation 2: Regional Estimates & Trend Analysis

6.1. North America

6.1.1. North America CD Targeted Bispecific Antibody Market revenue (US$ Million) estimates and forecasts By Target Type, 2022 - 2030

6.1.2. North America CD Targeted Bispecific Antibody Market revenue (US$ Million) estimates and forecasts by country, 2022 - 2030

6.2. Europe

6.2.1. Europe CD Targeted Bispecific Antibody Market revenue (US$ Million) By Target Type, 2022 - 2030

6.2.2. Europe CD Targeted Bispecific Antibody Market revenue (US$ Million) by country, 2022 - 2030

6.3. Asia Pacific

6.3.1. Asia Pacific CD Targeted Bispecific Antibody Market revenue (US$ Million) By Target Type, 2022 - 2030

6.3.2. Asia Pacific CD Targeted Bispecific Antibody Market revenue (US$ Million) by country, 2022 - 2030

6.4. Latin America

6.4.1. Latin America CD Targeted Bispecific Antibody Market revenue (US$ Million) By Target Type, (US$ Million)

6.4.2. Latin America CD Targeted Bispecific Antibody Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030

6.5. Middle East & Africa

6.5.1. Middle East & Africa CD Targeted Bispecific Antibody Market revenue (US$ Million) By Target Type, (US$ Million)

6.5.2. Middle East & Africa CD Targeted Bispecific Antibody Market revenue (US$ Million) by country, (US$ Million) 2022 - 2030

Chapter 7. Competitive Landscape

7.1. Major Mergers and Acquisitions/Strategic Alliances

7.2. Company Profiles

7.2.1. Aptevo Therapeutics

7.2.2. Affimed GmbH

7.2.3. Sutro Biopharma, Inc.

7.2.4. IGM Biosciences, Inc.

7.2.5. Xencor, Inc.

7.2.6. Amgen Inc.

7.2.7. Genentech USA, Inc.

7.2.8. Astella Pharma Inc.

7.2.9. Ben Kang Biopharmaceutical (Shenzhen) Co., Ltd.

7.2.10. Merus

7.2.11. Regeneron Pharmaceuticals, Inc.

7.2.12. Other Key Players

Global CD Targeted Bispecific Antibody Market Segmentation

Global CD Targeted Bispecific Antibody Market by Target Type

  • CD3
  • CD19
  • CD30/CD16A

 CD Targeted Bispecific Antibody Market

Global CD Targeted Bispecific Antibody Market Based on Region

Europe CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country

  • U.K.
  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

North America CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country

  • U.S.
  • Canada

Asia Pacific CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa CD Targeted Bispecific Antibody Market Outlook 2018-2028 by Country

  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

 

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

What is the CD Targeted Bispecific Antibody Market Growth?

Aptevo Therapeutics, Affimed GmbH, Sutro Biopharma, Inc., IGM Biosciences, Inc., Xencor, Inc., Amgen Inc., Genentech USA, Inc., Astella Pharma Inc., B

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Pharmaceuticals

Select Licence Type
$3786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach